Want to join the conversation?
Specialty biopharmaceutical company $MNK's effective tax rate for 1Q16 fell by 24.9 percentage points from 1Q15. This was predominately due to recent acquisitions and reorganizations, which resulted in more income in lower tax rate jurisdictions and less income in higher tax rate U.S. jurisdiction relative to income in all jurisdictions.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?